GNT Pharma

Quick facts

Phase 3 pipeline

• Neu2000KWL group · Neurology
  Neu2000KWL is a neuroprotective agent designed to reduce excitotoxic and oxidative damage in the central nervous system.

Phase 2 pipeline

• Neu2000KWL High-does group
• Neu2000KWL High-dose group
• Neu2000KWL Low-does group
• Neu2000KWL Low-dose group

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• GNT Pharma portfolio CI brief
• GNT Pharma pipeline updates RSS